Paid Clinical Trials in Farmington Hills, MI
As of September 2026, 116 paid clinical trials are recruiting in Farmington Hills, Michigan. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Farmington Hills offers studies at sites including Weisberg Cancer Treatment Center for conditions such as Parkinson Disease, Alzheimer Disease, Acute Myeloid Leukemia, Amyloid. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Farmington Hills
Trials by drug in Farmington Hills
Filter results
Newly added in Farmington Hills
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
109 clinical trials
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Study of Buntanetap in Participants With PD
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Registry for Stage 2 Type 1 Diabetes
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
C-Brace Prospective Registry
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Study of EVO756 in Adults With Migraine
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Top Research Study Locations in Farmington Hills
Researchers run research studies in Farmington Hills, MI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Weisberg Cancer Treatment Center | Stage II Lip and Oral Cavity Cancer AJCC v8, Stage III Laryngeal Cancer AJCC v8, Stage III Lip and Oral Cavity Cancer AJCC v8 | 27 |
| Quest Research Institute | Parkinson Disease, Alzheimers Disease, Advanced Parkinson's Disease | 23 |
| Corewell Health Farmington Hills Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Acute Lymphoblastic Leukemia | 15 |
| Michigan Center of Medical Research | Crohn Disease, Colitis, Ulcerative, Moderately to Severely Active Crohns Disease | 4 |
| Kailera Clinical Site | Obesity, Obesity With Diabetes, Overweight With Diabetes | 2 |
| Karmanos Cancer Institute Weisberg Cancer Treatment Center | Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage IIIA | 2 |
| Michigan Ear Institute | Tinnitus, Noise Induced, Tympanic Membrane Perforation | 2 |
| Michigan Healthcare Professionals Farmington | Locally Advanced Lung Non-Small Cell Carcinoma, Stage I Breast Cancer, Stage IIB Lung Cancer AJCC v8 | 2 |
| Michigan Institute of Neurological | Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis (SPMS) | 2 |
| Profound Research | Graves Disease, Graves' Disease, Transthyretin Amyloid Cardiomyopathy (ATTR CM) | 2 |
| Profound Research LLC | Atherosclerosis, Cardiovascular Diseases, Lipoprotein(a) | 2 |
| Profound Research LLC at Millenium Cardiology | Acute Myocardial Infarction, Atherosclerosis | 2 |
| Profound Research, LLC | KRAS G12C Lung Cancer, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer | 2 |
| Profound Research, Millennium Cardiology | Atrial Fibrillation (AF) | 2 |
| Quest Research Institute, Merz Investigational | Chronic Migraine, Episodic Migraine | 2 |
| Vima | Dystonia, PARKINSON DISEASE (Disorder) | 2 |
| ALX Center 8 | CRC (Colorectal Cancer), Colo-rectal Cancer, ESCC | 1 |
| Associated Endocrinologists, PC | Type 1 Diabetes | 1 |
| Atria Vascular and Vein | Arterial Disease of Legs, Below-the-knee Obstruction, PAD - Peripheral Arterial Disease | 1 |
| Detroit Clinical Research Center | Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion | 1 |
| GSK Investigational Site | Measles, Measles-Mumps-Rubella+Chickenpox Vaccine | 1 |
| GenesisCare USA - Farmington Hills | Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 | 1 |
| Karmanos Cancer Institute | Carcinoma, Non-Small-Cell Lung, Endometrial Cancer, Esophageal Squamous Cell Carcinoma | 1 |
| Michigan Healthcare Professionals | Hypothyroidism | 1 |
| Michigan Healthcare Professionals Pulse Cardiology | Heart Failure | 1 |
Active & Upcoming Studies in Farmington Hills (2026)
Recruiting trials in Farmington Hills grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (45 active studies)
- A Study of the TheraBionic P1 Device in Breast Cancer · Barbara Ann Karmanos Cancer Institute
- A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC) · Phase 3 · Hoffmann-La Roche
Neurology & pain (22 active studies)
- A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease · Phase 1 · Eli Lilly and Company
- A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease · Phase 1 · Eli Lilly and Company
Diabetes & metabolic (4 active studies)
Cardiovascular (4 active studies)
- Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable · Phase 3 · Regeneron Pharmaceuticals
- Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation · Phase 2 · Regeneron Pharmaceuticals
Vaccines (1 active study)
Common conditions studied in Farmington Hills
- Parkinson Disease (7 active studies)
- Alzheimer Disease (4 active studies)
- Acute Myeloid Leukemia (3 active studies)
- Amyloid (3 active studies)
- Graves' Disease (3 active studies)
- Parkinson's Disease (3 active studies)
Leading research sponsors in Farmington Hills
- National Cancer Institute (NCI)
- NRG Oncology
- AstraZeneca
- Eli Lilly and Company
- Hoffmann-La Roche
Frequently asked questions
How many paid clinical trials are currently recruiting in Farmington Hills?
There are approximately 116 recruiting clinical trials in Farmington Hills, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Farmington Hills pay participants?
Most recruiting trials in Farmington Hills compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Farmington Hills?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Farmington Hills?
The most common conditions under active study in Farmington Hills include Parkinson Disease (7), Alzheimer Disease (4), Acute Myeloid Leukemia (3), Amyloid (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Farmington Hills?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Farmington Hills on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Farmington Hills?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Farmington Hills?
Recruiting research sites in Farmington Hills include Weisberg Cancer Treatment Center, Quest Research Institute, Corewell Health Farmington Hills Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Farmington Hills right now?
The largest active categories in Farmington Hills are Cancer & tumors (45), Neurology & pain (22), Diabetes & metabolic (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.